24Sep
New AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC
As demand for rapid testing continues to accelerate at an unprecedented level, our response to assisting testing on a global scale must be in place to support accurate, reliable and easy-to-use testing.
The AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC, achieves 98.03% sensitivity and 99.5% specifically, will play an invaluable role in overcoming unpredicted rapid testing outcomes.
Download the whitepaper to learn:
- How the body responds to SARS-COV-2
- The different approaches to antibody testing
- The UK-RTC Abc-19 Rapid Test
- The link between antibodies and immunity
- The route towards therapies and immunisation
Please access the complete whitepaper for this device here.
Related
The North East Innovation Lab, originally established as part of the region’s integrated Covid hub,...
Read More >
SYDNEY, AUSTRALIA – (April 19, 2018). SpeeDx’s ResistancePlus® MG Positive Control kit has now bee...
Read More >
FDA cleared POC hemoglobin analyzer to be sold across the USA by the market’s leading and most esta...
Read More >
8 March 2018: Oxford & Manchester, UK. Cytox, an emerging precision medicine leader providing geneti...
Read More >
Transaction expands BioIVT’s donor network and increases its capacity to provide fresh whole blood,...
Read More >
New Range of CE Certified Face Visors and Type II Masks with Introductory 10% Savings
Read More >